This study will evaluate the safety and effectiveness of the FDA approved UltraClear laser device for the improvement of skin appearance and skin texture. The cosmetic device uses a skin peeling process to improve skin properties such as softness, elasticity, and appearance. Participation in this study requires attending 5-6 study visits over a 7–8-month period. Study visits will take place at the Scripps Clinic Carmel Valley.
- Be between 18 and 75 years of age
- Have clinically identifiable photodamage on facial skin, neck, or chest
- Be willing and able to comply with all follow-up requirements
- Meet all other eligibility requirements
Patients must not:
- Have active localized or systemic infections
- Have a compromised ability for wound healing, such as: malnutrition, steroid use, history of collagen vascular disease, atrophic dermatitis, or immunologic abnormalities such as vitiligo
- Be currently taking Accutane
- Have a known allergy to lidocaine (numbing cream)
- Have used topical steroids or retinoids within the last 3 months on treatment surfaces
- Have a personal history of malignant melanoma, keloid scars, generalized psoriasis or systemic diseases that would preclude the use of topical anesthesia
- Use cosmeceutical agents or topical agents during the course of the study, except as directed by study investigators
- Be pregnant
- Be exposed to excessive sun burn over the past 2 months
The UltraClear Laser system is intended to improve photodamage by reducing fine lines, wrinkles, and acne scars and improving skin tone, appearance and texture.